Pospisilik, J Andrew <br/><br/>
Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.  [electronic resource] 

 -  Cell  Nov 2007 
 - 476-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0092-8674 
<br/><br/><label>Standard No.: </label>10.1016/j.cell.2007.08.047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis Inducing Factor--deficiency<br/>Cell Respiration--drug effects<br/>Diabetes Mellitus--genetics<br/>Diet--adverse effects<br/>Gene Deletion<br/>Gene Targeting<br/>Glucose--metabolism<br/>Insulin--pharmacology<br/>Liver--cytology<br/>Mice<br/>Mice, Knockout<br/>Mitochondria--drug effects<br/>Mosaicism--drug effects<br/>Muscles--cytology<br/>Obesity--genetics<br/>Organ Specificity--drug effects<br/>Oxidative Phosphorylation--drug effects<br/>Phenotype<br/>Substrate Specificity--drug effects